Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005759 | mitochondrial matrix | 5 | 11 |
GO:0031974 | membrane-enclosed lumen | 2 | 11 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 11 |
GO:0070013 | intracellular organelle lumen | 4 | 11 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: Q4Q7Z1
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 2 |
GO:0006629 | lipid metabolic process | 3 | 2 |
GO:0006631 | fatty acid metabolic process | 4 | 2 |
GO:0006950 | response to stress | 2 | 11 |
GO:0006974 | DNA damage response | 4 | 11 |
GO:0006996 | organelle organization | 4 | 11 |
GO:0007005 | mitochondrion organization | 5 | 11 |
GO:0007006 | mitochondrial membrane organization | 5 | 11 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016043 | cellular component organization | 3 | 11 |
GO:0019752 | carboxylic acid metabolic process | 5 | 2 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 2 |
GO:0033554 | cellular response to stress | 3 | 11 |
GO:0043436 | oxoacid metabolic process | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044255 | cellular lipid metabolic process | 3 | 2 |
GO:0044281 | small molecule metabolic process | 2 | 2 |
GO:0046902 | regulation of mitochondrial membrane permeability | 4 | 11 |
GO:0050896 | response to stimulus | 1 | 11 |
GO:0051716 | cellular response to stimulus | 2 | 11 |
GO:0061024 | membrane organization | 4 | 11 |
GO:0065007 | biological regulation | 1 | 11 |
GO:0065008 | regulation of biological quality | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 11 |
GO:0090559 | regulation of membrane permeability | 3 | 11 |
GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death | 5 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 110 | 114 | PF00656 | 0.599 |
CLV_C14_Caspase3-7 | 81 | 85 | PF00656 | 0.553 |
CLV_NRD_NRD_1 | 237 | 239 | PF00675 | 0.539 |
CLV_NRD_NRD_1 | 260 | 262 | PF00675 | 0.495 |
CLV_NRD_NRD_1 | 280 | 282 | PF00675 | 0.275 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.645 |
CLV_PCSK_KEX2_1 | 237 | 239 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 260 | 262 | PF00082 | 0.465 |
CLV_PCSK_KEX2_1 | 280 | 282 | PF00082 | 0.275 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.620 |
CLV_PCSK_PC7_1 | 2 | 8 | PF00082 | 0.667 |
CLV_PCSK_SKI1_1 | 188 | 192 | PF00082 | 0.385 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.671 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.426 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.660 |
DOC_CYCLIN_RxL_1 | 2 | 13 | PF00134 | 0.658 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 118 | 127 | PF00134 | 0.583 |
DOC_CYCLIN_yCln2_LP_2 | 192 | 198 | PF00134 | 0.343 |
DOC_MAPK_gen_1 | 237 | 245 | PF00069 | 0.558 |
DOC_MAPK_gen_1 | 260 | 269 | PF00069 | 0.393 |
DOC_MAPK_HePTP_8 | 267 | 279 | PF00069 | 0.336 |
DOC_MAPK_MEF2A_6 | 270 | 279 | PF00069 | 0.344 |
DOC_PP1_RVXF_1 | 151 | 157 | PF00149 | 0.372 |
DOC_PP2B_LxvP_1 | 116 | 119 | PF13499 | 0.570 |
DOC_PP4_FxxP_1 | 31 | 34 | PF00568 | 0.427 |
DOC_PP4_FxxP_1 | 72 | 75 | PF00568 | 0.435 |
DOC_USP7_MATH_1 | 128 | 132 | PF00917 | 0.436 |
DOC_WW_Pin1_4 | 245 | 250 | PF00397 | 0.442 |
DOC_WW_Pin1_4 | 254 | 259 | PF00397 | 0.454 |
DOC_WW_Pin1_4 | 270 | 275 | PF00397 | 0.258 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.494 |
LIG_14-3-3_CanoR_1 | 173 | 179 | PF00244 | 0.417 |
LIG_14-3-3_CanoR_1 | 188 | 193 | PF00244 | 0.375 |
LIG_14-3-3_CanoR_1 | 238 | 244 | PF00244 | 0.551 |
LIG_14-3-3_CanoR_1 | 260 | 268 | PF00244 | 0.432 |
LIG_14-3-3_CanoR_1 | 79 | 83 | PF00244 | 0.547 |
LIG_deltaCOP1_diTrp_1 | 221 | 228 | PF00928 | 0.378 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.585 |
LIG_FHA_1 | 174 | 180 | PF00498 | 0.488 |
LIG_FHA_1 | 263 | 269 | PF00498 | 0.378 |
LIG_FHA_1 | 274 | 280 | PF00498 | 0.418 |
LIG_FHA_1 | 51 | 57 | PF00498 | 0.488 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.564 |
LIG_FHA_2 | 60 | 66 | PF00498 | 0.474 |
LIG_LIR_Apic_2 | 30 | 34 | PF02991 | 0.456 |
LIG_LIR_Apic_2 | 53 | 58 | PF02991 | 0.465 |
LIG_LIR_Apic_2 | 71 | 75 | PF02991 | 0.512 |
LIG_LIR_Gen_1 | 100 | 108 | PF02991 | 0.519 |
LIG_LIR_Gen_1 | 74 | 82 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 74 | 80 | PF02991 | 0.412 |
LIG_LIR_Nem_3 | 96 | 101 | PF02991 | 0.387 |
LIG_PALB2_WD40_1 | 72 | 80 | PF16756 | 0.404 |
LIG_PCNA_PIPBox_1 | 87 | 96 | PF02747 | 0.448 |
LIG_Pex14_1 | 51 | 55 | PF04695 | 0.480 |
LIG_Pex14_2 | 72 | 76 | PF04695 | 0.432 |
LIG_SH2_CRK | 101 | 105 | PF00017 | 0.460 |
LIG_SH2_NCK_1 | 101 | 105 | PF00017 | 0.466 |
LIG_SH2_PTP2 | 212 | 215 | PF00017 | 0.453 |
LIG_SH2_PTP2 | 55 | 58 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 144 | 147 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 212 | 215 | PF00017 | 0.358 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.476 |
LIG_SH3_3 | 122 | 128 | PF00018 | 0.557 |
LIG_SH3_3 | 13 | 19 | PF00018 | 0.647 |
LIG_SH3_3 | 143 | 149 | PF00018 | 0.444 |
LIG_SH3_3 | 192 | 198 | PF00018 | 0.475 |
LIG_SH3_3 | 29 | 35 | PF00018 | 0.476 |
LIG_SUMO_SIM_anti_2 | 200 | 206 | PF11976 | 0.445 |
LIG_TRAF2_1 | 35 | 38 | PF00917 | 0.563 |
LIG_TRAF2_1 | 62 | 65 | PF00917 | 0.474 |
MOD_CDK_SPxK_1 | 245 | 251 | PF00069 | 0.574 |
MOD_CDK_SPxK_1 | 254 | 260 | PF00069 | 0.437 |
MOD_CDK_SPxxK_3 | 254 | 261 | PF00069 | 0.581 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.421 |
MOD_CK1_1 | 21 | 27 | PF00069 | 0.458 |
MOD_CK1_1 | 262 | 268 | PF00069 | 0.429 |
MOD_CK1_1 | 273 | 279 | PF00069 | 0.469 |
MOD_CK2_1 | 59 | 65 | PF00069 | 0.452 |
MOD_GlcNHglycan | 161 | 164 | PF01048 | 0.418 |
MOD_GSK3_1 | 169 | 176 | PF00069 | 0.415 |
MOD_N-GLC_1 | 173 | 178 | PF02516 | 0.386 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.441 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.441 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.398 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.408 |
MOD_PIKK_1 | 102 | 108 | PF00454 | 0.439 |
MOD_PKA_2 | 172 | 178 | PF00069 | 0.445 |
MOD_PKA_2 | 259 | 265 | PF00069 | 0.468 |
MOD_PKA_2 | 78 | 84 | PF00069 | 0.552 |
MOD_Plk_1 | 262 | 268 | PF00069 | 0.436 |
MOD_Plk_1 | 65 | 71 | PF00069 | 0.530 |
MOD_Plk_2-3 | 59 | 65 | PF00069 | 0.554 |
MOD_Plk_2-3 | 78 | 84 | PF00069 | 0.539 |
MOD_Plk_4 | 140 | 146 | PF00069 | 0.452 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.498 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.492 |
MOD_Plk_4 | 273 | 279 | PF00069 | 0.507 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.525 |
MOD_ProDKin_1 | 245 | 251 | PF00069 | 0.449 |
MOD_ProDKin_1 | 254 | 260 | PF00069 | 0.455 |
MOD_ProDKin_1 | 270 | 276 | PF00069 | 0.262 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.490 |
MOD_SUMO_rev_2 | 59 | 69 | PF00179 | 0.514 |
TRG_DiLeu_BaEn_1 | 200 | 205 | PF01217 | 0.418 |
TRG_DiLeu_BaEn_1 | 65 | 70 | PF01217 | 0.391 |
TRG_DiLeu_BaEn_4 | 65 | 71 | PF01217 | 0.417 |
TRG_DiLeu_BaLyEn_6 | 4 | 9 | PF01217 | 0.684 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.372 |
TRG_ENDOCYTIC_2 | 212 | 215 | PF00928 | 0.358 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.370 |
TRG_ER_diArg_1 | 217 | 220 | PF00400 | 0.473 |
TRG_ER_diArg_1 | 236 | 238 | PF00400 | 0.326 |
TRG_ER_diArg_1 | 259 | 261 | PF00400 | 0.495 |
TRG_ER_diArg_1 | 279 | 281 | PF00400 | 0.265 |
TRG_ER_diArg_1 | 282 | 285 | PF00400 | 0.601 |
TRG_ER_diArg_1 | 5 | 7 | PF00400 | 0.648 |
TRG_NES_CRM1_1 | 234 | 246 | PF08389 | 0.494 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HYL5 | Leptomonas seymouri | 76% | 98% |
A0A0S4JCJ0 | Bodo saltans | 47% | 89% |
A0A1X0NR19 | Trypanosomatidae | 60% | 100% |
A0A3Q8IE10 | Leishmania donovani | 96% | 100% |
A4HGX4 | Leishmania braziliensis | 84% | 99% |
A4I404 | Leishmania infantum | 95% | 100% |
D0A901 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
E9B094 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
V5B945 | Trypanosoma cruzi | 58% | 100% |